RATIO-DOXAZOSIN DIN 02243216
Status: Cancelled Post Market
Holder: RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED
Molecule: DOXAZOSIN (DOXAZOSIN MESYLATE)
Health Canada record
| Active ingredient(s) | DOXAZOSIN (DOXAZOSIN MESYLATE) 2 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | C02CA04 DOXAZOSIN |
| Original market date | 13-Feb-2001 |
| Current status date | 04-Aug-2006 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing DOXAZOSIN (DOXAZOSIN MESYLATE)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02240588 | APO-DOXAZOSIN | APOTEX INC | Tablet | DOXAZOSIN (DOXAZOSIN MESYLATE) 1 MG | Marketed |
| 02240590 | APO-DOXAZOSIN | APOTEX INC | Tablet | DOXAZOSIN (DOXAZOSIN MESYLATE) 4 MG | Marketed |
| 02240589 | APO-DOXAZOSIN | APOTEX INC | Tablet | DOXAZOSIN (DOXAZOSIN MESYLATE) 2 MG | Marketed |
| 02489953 | JAMP-DOXAZOSIN | JAMP PHARMA CORPORATION | Tablet | DOXAZOSIN (DOXAZOSIN MESYLATE) 4 MG | Marketed |
| 02489945 | JAMP-DOXAZOSIN | JAMP PHARMA CORPORATION | Tablet | DOXAZOSIN (DOXAZOSIN MESYLATE) 2 MG | Marketed |
| 02489937 | JAMP-DOXAZOSIN | JAMP PHARMA CORPORATION | Tablet | DOXAZOSIN (DOXAZOSIN MESYLATE) 1 MG | Marketed |
| 02242728 | TEVA-DOXAZOSIN | TEVA CANADA LIMITED | Tablet | DOXAZOSIN (DOXAZOSIN MESYLATE) 1 MG | Marketed |
| 02242729 | TEVA-DOXAZOSIN | TEVA CANADA LIMITED | Tablet | DOXAZOSIN (DOXAZOSIN MESYLATE) 2 MG | Marketed |
| 02242730 | TEVA-DOXAZOSIN | TEVA CANADA LIMITED | Tablet | DOXAZOSIN (DOXAZOSIN MESYLATE) 4 MG | Marketed |
| 01958100 | CARDURA-1 TAB 1MG | PFIZER CANADA ULC | Tablet | DOXAZOSIN (DOXAZOSIN MESYLATE) 1 MG | Cancelled Post Market |
| 02231762 | CARDURA-1,2,AND 4 | ASTRAZENECA CANADA INC | Tablet; Kit | DOXAZOSIN (DOXAZOSIN MESYLATE) 1 MG; DOXAZOSIN (DOXAZOSIN MESYLATE) 2 MG; DOXAZOSIN (DOXAZOSIN MESYLATE) 4 MG | Cancelled Pre Market |
| 01958097 | CARDURA-2 TAB 2MG | PFIZER CANADA ULC | Tablet | DOXAZOSIN (DOXAZOSIN MESYLATE) 2 MG | Cancelled Post Market |
| 01958119 | CARDURA-4 TAB 4MG | PFIZER CANADA ULC | Tablet | DOXAZOSIN (DOXAZOSIN MESYLATE) 4 MG | Cancelled Post Market |
| 02246333 | DOM-DOXAZOSIN | DOMINION PHARMACAL | Tablet | DOXAZOSIN (DOXAZOSIN MESYLATE) 2 MG | Cancelled Post Market |
| 02246334 | DOM-DOXAZOSIN | DOMINION PHARMACAL | Tablet | DOXAZOSIN (DOXAZOSIN MESYLATE) 4 MG | Cancelled Post Market |
| 02246332 | DOM-DOXAZOSIN | DOMINION PHARMACAL | Tablet | DOXAZOSIN (DOXAZOSIN MESYLATE) 1 MG | Cancelled Post Market |
| 02240978 | DOXAZOSIN-1 | PRO DOC LIMITEE | Tablet | DOXAZOSIN (DOXAZOSIN MESYLATE) 1 MG | Cancelled Post Market |
| 02240979 | DOXAZOSIN-2 | PRO DOC LIMITEE | Tablet | DOXAZOSIN (DOXAZOSIN MESYLATE) 2 MG | Cancelled Post Market |
| 02240980 | DOXAZOSIN-4 | PRO DOC LIMITEE | Tablet | DOXAZOSIN (DOXAZOSIN MESYLATE) 4 MG | Cancelled Post Market |
| 02240498 | MYLAN-DOXAZOSIN | MYLAN PHARMACEUTICALS ULC | Tablet | DOXAZOSIN (DOXAZOSIN MESYLATE) 1 MG | Cancelled Post Market |
| 02240500 | MYLAN-DOXAZOSIN | MYLAN PHARMACEUTICALS ULC | Tablet | DOXAZOSIN (DOXAZOSIN MESYLATE) 4 MG | Cancelled Post Market |
| 02240499 | MYLAN-DOXAZOSIN | MYLAN PHARMACEUTICALS ULC | Tablet | DOXAZOSIN (DOXAZOSIN MESYLATE) 2 MG | Cancelled Post Market |
| 02244527 | PMS-DOXAZOSIN | PHARMASCIENCE INC | Tablet | DOXAZOSIN (DOXAZOSIN MESYLATE) 1 MG | Cancelled Post Market |
| 02244529 | PMS-DOXAZOSIN | PHARMASCIENCE INC | Tablet | DOXAZOSIN (DOXAZOSIN MESYLATE) 4 MG | Cancelled Post Market |
| 02244528 | PMS-DOXAZOSIN | PHARMASCIENCE INC | Tablet | DOXAZOSIN (DOXAZOSIN MESYLATE) 2 MG | Cancelled Post Market |
| 02243217 | RATIO-DOXAZOSIN | RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED | Tablet | DOXAZOSIN (DOXAZOSIN MESYLATE) 4 MG | Cancelled Post Market |
| 02243215 | RATIO-DOXAZOSIN | RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED | Tablet | DOXAZOSIN (DOXAZOSIN MESYLATE) 1 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 447 | 2002-05-01 | Abbreviated New Drug Submission (ANDS) | CHANGE IN MANUFACTURER AND PRODUCT NAME |
| 2192 | 2001-01-18 | Abbreviated New Drug Submission (ANDS) |